Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus.

Source:http://linkedlifedata.com/resource/pubmed/id/21121772

Download in:

View as

General Info

PMID
21121772